Sara E. Mansell

452 total citations
8 papers, 366 citations indexed

About

Sara E. Mansell is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Sara E. Mansell has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Sara E. Mansell's work include Drug Transport and Resistance Mechanisms (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Sara E. Mansell is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Diet, Metabolism, and Disease (2 papers). Sara E. Mansell collaborates with scholars based in Canada and United States. Sara E. Mansell's co-authors include Richard B. Kim, Rommel G. Tirona, Wendy A. Teft, Melanie Beaton, Sarah Woolsey, Inna Y. Gong, Robert A. Hegele, Aze Wilson, Richard Ho and Bridget L. Morse and has published in prestigious journals such as Hepatology, Molecular Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Sara E. Mansell

8 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara E. Mansell Canada 7 136 109 95 81 59 8 366
Dhanashri Kolwankar United States 8 173 1.3× 158 1.4× 70 0.7× 128 1.6× 66 1.1× 8 419
Ansar A. Khan India 9 147 1.1× 94 0.9× 48 0.5× 52 0.6× 84 1.4× 20 338
Zhengbo Duanmu United States 12 88 0.6× 162 1.5× 132 1.4× 54 0.7× 44 0.7× 18 423
Choon Ok Kim South Korea 12 130 1.0× 48 0.4× 73 0.8× 63 0.8× 65 1.1× 48 376
Shuichi Fukuen Japan 6 150 1.1× 226 2.1× 121 1.3× 33 0.4× 74 1.3× 6 419
Matthew D. Merrell United States 9 117 0.9× 108 1.0× 92 1.0× 152 1.9× 36 0.6× 11 343
Su-Er W. Huskey United States 11 127 0.9× 194 1.8× 133 1.4× 31 0.4× 56 0.9× 13 548
Michael J. Knauer Canada 12 191 1.4× 92 0.8× 94 1.0× 47 0.6× 101 1.7× 25 603
Yanrong Ma China 12 91 0.7× 73 0.7× 122 1.3× 44 0.5× 44 0.7× 49 374
Kaijing Zhao China 12 132 1.0× 101 0.9× 97 1.0× 29 0.4× 50 0.8× 22 314

Countries citing papers authored by Sara E. Mansell

Since Specialization
Citations

This map shows the geographic impact of Sara E. Mansell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Mansell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Mansell more than expected).

Fields of papers citing papers by Sara E. Mansell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara E. Mansell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Mansell. The network helps show where Sara E. Mansell may publish in the future.

Co-authorship network of co-authors of Sara E. Mansell

This figure shows the co-authorship network connecting the top 25 collaborators of Sara E. Mansell. A scholar is included among the top collaborators of Sara E. Mansell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara E. Mansell. Sara E. Mansell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Russell, Laura, Marianne K. DeGorter, Richard Ho, et al.. (2021). Mouse NTCP–Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice. The AAPS Journal. 23(1). 17–17. 3 indexed citations
2.
Knauer, Michael J., Sara E. Mansell, Crystal L. Schmerk, et al.. (2019). Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1. Drug Metabolism and Disposition. 47(8). 832–842. 42 indexed citations
3.
Woolsey, Sarah, Melanie Beaton, Sara E. Mansell, et al.. (2016). A Fibroblast Growth Factor 21–Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease. Molecular Pharmacology. 90(4). 437–446. 27 indexed citations
4.
Teft, Wendy A., Bridget L. Morse, Brenda F. Leake, et al.. (2016). Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters. Molecular Pharmaceutics. 14(1). 310–318. 61 indexed citations
5.
Woolsey, Sarah, Sara E. Mansell, Richard B. Kim, Rommel G. Tirona, & Melanie Beaton. (2015). CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition. 43(10). 1484–1490. 111 indexed citations
6.
Gong, Inna Y., Sara E. Mansell, & Richard B. Kim. (2012). Absence of bothMDR1 (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Transporters Significantly Alters Rivaroxaban Disposition and Central Nervous System Entry. Basic & Clinical Pharmacology & Toxicology. 112(3). 164–170. 42 indexed citations
7.
Schwabedissen, Henriette E. Meyer zu, Joseph A. Ware, David Finkelstein, et al.. (2011). Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis. Hepatology. 54(2). 644–654. 23 indexed citations
8.
Teft, Wendy A., Sara E. Mansell, & Richard B. Kim. (2010). Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1). Drug Metabolism and Disposition. 39(3). 558–562. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026